Fast Start To Oral Phenylephrine Efficacy Complaints As US FDA Considers 'Any Action'
Class Action Complaints Don’t Wait For Potential Action On Oral Phenylephrine By US FDA
Two days after FDA advisory panel’s meeting to discuss whether oral phenylephrine is effective for nasal congestion, complaints filed in federal court in multiple states alleging manufacturers knowingly misled public about ingredient’s efficacy. FDA’s potential response to NDAC’S finding wouldn’t come as soon.
